Where does TransMedics Group, Inc.'s cash flow data come from?

Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	$171.92M-9.7%	$190.29M+107%	$91.77M+28.1%	$71.66M+46.4%	$48.95M+38.0%
Depreciation and amortization	$32.91M+21.1%	$27.19M+7.0%	$25.4M+7.0%	$23.73M+9.9%	$21.59M+9.3%
Stock-based compensation	$37.86M+2.7%	$36.86M-3.6%	$38.23M+3.2%	$37.04M+4.9%	$35.31M+6.3%
Deferred income taxes	-$61.59M+26.3%	-$83.54M—	——	——	——
Gain (loss) on sale of assets	——	——	——	——	-$92.75K-446%
Change in accounts receivable	——	——	——	——	$60.79M+73.4%
Change in inventories	$13.62M+76.5%	$7.72M—	——	——	——
Change in accounts payable	$326K+1,816%	-$19K+98.3%	-$1.09M+69.5%	-$3.58M-352%	$1.42M+202%
Change in accrued liabilities	$19.23M+8.7%	$17.69M+35.6%	$13.05M+167%	$4.9M+46.4%	$3.34M-57.9%
Change in other assets	——	——	——	——	——
Change in deferred revenue	——	——	$1.11M+921%	$109K+474%	$19K+109%
Change in operating lease liabilities	-$3.04M-4.9%	-$2.9M-5.0%	-$2.76M-4.3%	-$2.64M-8.6%	-$2.43M-7.4%
Net cash from operating activities	$220.23M+14.2%	$192.84M+8.3%	$177.99M+54.4%	$115.27M+133%	$49.38M+1.2%
Capital expenditures	$68.87M+16.2%	$59.25M+3.3%	$57.34M-41.4%	$97.92M-13.0%	$112.61M-13.2%
Net cash from investing activities	-$68.87M-16.2%	-$59.25M-3.3%	-$57.34M+41.2%	-$97.48M+13.1%	-$112.17M+13.3%
Proceeds from issuance of debt	——	——	——	——	——
Proceeds from issuance of common stock	$14.22M+3.4%	$13.75M+16.2%	$11.83M-28.1%	$16.46M-17.8%	$20.01M-3.9%
Taxes paid for net share settlement	$241.5K+75.0%	$138K—	——	——	——
Net cash from financing activities	$17.59M+4.4%	$16.86M+12.8%	$14.94M-22.0%	$19.17M-15.6%	$22.72M-0.7%
Effect of exchange rate changes on cash	$585K-53.9%	$1.27M+160%	$489K-43.5%	$866K+17,420%	-$5K+99.1%
Net increase (decrease) in cash	$169.53M+11.7%	$151.72M—	——	——	——
Interest paid	——	$10.7M-1.4%	$10.85M-1.4%	$11M-1.3%	$11.15M-1.3%
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax	$563K-65.3%	$1.62M+203%	$536K-46.8%	$1.01M+842%	$107K+116%
Gain (Loss) on Disposition of Assets	——	——	——	——	-$92.75K-446%
Accrued expenses and other liabilities	$19.23M+8.7%	$17.69M+35.6%	$13.05M+167%	$4.9M+46.4%	$3.34M-57.9%
Operating lease liabilities	-$3.04M-4.9%	-$2.9M-5.0%	-$2.76M-4.3%	-$2.64M-8.6%	-$2.43M-7.4%
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——	$2.76M-56.0%
Non Cash Interest Expense	——	——	——	——	——
Non Cash Operating Lease Expense	——	——	——	——	——
Proceeds from issuance of common stock relating to employee stock plans	——	——	——	——	——
Accrued payables for capital expenditures	$1.75M-1.9%	$1.79M-38.8%	$2.92M—	——	——
Value of common stock issued to settle convertible senior notes	——	——	——	——	——
Increase Decrease In Contract With Customer Liability	——	——	$1.11M+921%	$109K+474%	$19K+109%
Increase Decrease In Operating Lease Liability	-$3.04M-4.9%	-$2.9M-5.0%	-$2.76M-4.3%	-$2.64M-8.6%	-$2.43M-7.4%
Inventory Transfer To Property Plant And Equipment	$7.24M+27.4%	$5.68M+20.0%	$4.73M+1.3%	$4.67M-20.3%	$5.86M+1.0%
Accrued payables for stock repurchases, including applicable excise tax	——	——	——	——	——
Leased assets obtained in exchange for finance lease liabilities	——	——	——	——	——
Leased assets obtained in exchange for operating lease liabilities	——	——	——	——	——
Free cash flow	$151.36M+13.3%	$133.59M—	——	——	——
Free cash flow	$151.36M+13.3%	$133.59M—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does TransMedics Group, Inc.'s cash flow data come from?: Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.